Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species (Q37038026)

17 August 2017

1 reference

title

Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species (English)

1 reference

17 August 2017

0 references

1 reference

reactive oxygen species

1 reference

0 references

1 reference

Yongzhong Wei

1

1 reference

17 August 2017

Kemin Chen

2

1 reference

17 August 2017

Adam T Whaley-Connell

3

1 reference

17 August 2017

Craig S Stump

4

1 reference

17 August 2017

Jamal A Ibdah

5

1 reference

17 August 2017

James R Sowers

6

1 reference

17 August 2017

language of work or name

1 reference

19 December 2007

1 reference

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

17 August 2017

1 reference

17 August 2017

294

1 reference

17 August 2017

R673-80

1 reference

17 August 2017

3

1 reference

Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6.

17 August 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

THIS ARTICLE HAS BEEN RETRACTED Exercise induces interleukin-8 expression in human skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Pathogen recognition and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Cross-talk between skeletal muscle and adipose tissue: a link with obesity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Nitric oxide induces [Ca2+]i oscillations in pituitary GH3 cells: involvement of IDR and ERG K+ currents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Neutralization of tumor necrosis factor-alpha reverses insulin resistance in skeletal muscle but not adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

MAP4K4 gene silencing in human skeletal muscle prevents tumor necrosis factor-alpha-induced insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Toll-like receptors differentially regulate CC and CXC chemokines in skeletal muscle via NF-kappaB and calcineurin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Vascular inflammation and the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Physical activity and modulation of systemic low-level inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Interleukin-15 increases glucose uptake in skeletal muscle. An antidiabetogenic effect of the cytokine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Endogenous interleukin-10 protects against hepatic steatosis but does not improve insulin sensitivity during high-fat feeding in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

The role of interleukin-1 in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Multiple Toll-like receptor ligands induce an IL-6 transcriptional response in skeletal myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Increased oxidative stress in obesity and its impact on metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Exercise training and the antioxidant alpha-lipoic acid in the treatment of insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

A central role for JNK in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Reactive oxygen species have a causal role in multiple forms of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Minireview: recent developments in the regulation of glucose transporter-4 traffic: new signals, locations, and partners

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Socs1 deficiency enhances hepatic insulin signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Endotoxin stimulates in vivo expression of inflammatory cytokines tumor necrosis factor alpha, interleukin-1beta, -6, and high-mobility-group protein-1 in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Sulfasalazine and BAY 11-7082 interfere with the nuclear factor-kappa B and I kappa B kinase pathway to regulate the release of proinflammatory cytokines from human adipose tissue and skeletal muscle in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Roles of skeletal muscle and peroxisome proliferator-activated receptors in the development and treatment of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Obesity induces a phenotypic switch in adipose tissue macrophage polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by mircomolar concentrations of alpha-lipoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-1beta in human islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Glucose- and interleukin-1beta-induced beta-cell apoptosis requires Ca2+ influx and extracellular signal-regulated kinase (ERK) 1/2 activation and is prevented by a sulfonylurea receptor 1/inwardly rectifying K+ channel 6.2 (SUR/Kir6.2) selective po

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

The membrane form of the type II IL-1 receptor accounts for inhibitory function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Muscle-derived interleukin-6: possible biological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Interleukin-15: a novel anabolic cytokine for skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Interleukin-15 stimulates adiponectin secretion by 3T3-L1 adipocytes: evidence for a skeletal muscle-to-fat signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Angiotensin II induces insulin resistance independent of changes in interstitial insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Interleukin-6 regulation of AMP-activated protein kinase. Potential role in the systemic response to exercise and prevention of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Lipoic acid protects against oxidative stress induced impairment in insulin stimulation of protein kinase B and glucose transport in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

The expression of TNF alpha by human muscle. Relationship to insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Monocyte chemotactic protein-1 is a potential player in the negative cross-talk between adipose tissue and skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Inflammation and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

The metabolic syndrome: role of skeletal muscle metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Reactive oxygen species in the vasculature: molecular and cellular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. A putative cellular mechanism for impaired protein kinase B activation and GLUT4 translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

The contribution of skeletal muscle tumor necrosis factor-alpha to insulin resistance and hypertension in fructose-fed rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Effect of TNF-alpha--converting enzyme inhibitor on insulin resistance in fructose-fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Inflammation and nitric oxide production in skeletal muscle of type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Cooperation of Toll-like receptor signals in innate immune defence

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Oxidative stress is associated with adiposity and insulin resistance in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-kappaB activation via NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Direct cross-talk of interleukin-6 and insulin signal transduction via insulin receptor substrate-1 in skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Inflammation, stress, and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Olmesartan ameliorates insulin sensitivity by modulating tumor necrosis factor-alpha and cyclic AMP in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Cytokines and endotoxin induce cytokine receptors in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00561.2007

10.1152/AJPREGU.00561.2007

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference